Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective.
Alessandra BorgheresiFederica De MuzioAndrea AgostiniLetizia OttavianiAlessandra BrunoVincenza GranataRoberta FuscoGinevra DantiFederica FlammiaRoberta GrassiFrancesca GrassiFederico BrunoPierpaolo PalumboAntonio BarileVittorio MieleAndrea GiovagnoniPublished in: Journal of clinical medicine (2022)
The assessment of nodal involvement in patients with rectal cancer (RC) is fundamental in disease management. Magnetic Resonance Imaging (MRI) is routinely used for local and nodal staging of RC by using morphological criteria. The actual dimensional and morphological criteria for nodal assessment present several limitations in terms of sensitivity and specificity. For these reasons, several different techniques, such as Diffusion Weighted Imaging (DWI), Intravoxel Incoherent Motion (IVIM), Diffusion Kurtosis Imaging (DKI), and Dynamic Contrast Enhancement (DCE) in MRI have been introduced but still not fully validated. Positron Emission Tomography (PET)/CT plays a pivotal role in the assessment of LNs; more recently PET/MRI has been introduced. The advantages and limitations of these imaging modalities will be provided in this narrative review. The second part of the review includes experimental techniques, such as iron-oxide particles (SPIO), and dual-energy CT (DECT). Radiomics analysis is an active field of research, and the evidence about LNs in RC will be discussed. The review also discusses the different recommendations between the European and North American guidelines for the evaluation of LNs in RC, from anatomical considerations to structured reporting.
Keyphrases
- contrast enhanced
- diffusion weighted imaging
- computed tomography
- positron emission tomography
- pet ct
- magnetic resonance imaging
- dual energy
- lymph node
- diffusion weighted
- rectal cancer
- magnetic resonance
- neoadjuvant chemotherapy
- high resolution
- image quality
- locally advanced
- pet imaging
- clinical practice
- emergency department
- sentinel lymph node
- lymph node metastasis
- radiation therapy
- mass spectrometry
- adverse drug